Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Italy Leads European Push Into Conditional Reimbursement

Executive Summary

Italy claims to have pushed farther into managed entry agreements than other European countries with strong clawback provisions on new drugs – particularly cancer drugs – if they don't work as well as their manufacturers claim. The financial clawbacks are supported by extensive outcome data collection across the country's twenty regions.

You may also be interested in...



EMA Director-Nominee Guido Rasi Brings Track Record For Repairing Regulatory Agency Reputation

Rasi leads the Italian Medicines Agency, an agency also known for conditional reimbursement agreements.

EMA Director-Nominee Guido Rasi Brings Track Record For Repairing Regulatory Agency Reputation

Rasi leads the Italian Medicines Agency, an agency also known for conditional reimbursement agreements.

Celgene Ups Vidaza Discount To Gain Positive NICE Recommendation

U.K. cost-watchdog NICE recommends reimbursement for Celgene's Vidaza after the company offers a steeper discount.

Topics

Latest News
See All
UsernamePublicRestriction

Register

PS053353

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel